SEC Form 4 · accession 0002040705-26-000007
KYNTRA BIO, INC. · KYNB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David DeLucia
Officer — Chief Financial Officer
Period of report
Sep 6, 2026
Accepted (ET)
Sep 9, 2026 · 8:41 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0000921299
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Sep 6, 2026 | F | 22 | $8.55 | D | 4,355 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units.